心血管疾病中的自主失衡:分子机制和新兴治疗方法
Lilian R Mott1, Jessica L Caldwell1
1Department of Pharmacology, University of California Davis, Davis, California, United States.
American journal of physiology. Cell physiology
|October 6, 2025
概括
自主性失衡通过中断的信号传递驱动心血管疾病. 新疗法旨在通过准分子通路和神经信号来恢复平衡,以提高治疗精度.
科学领域:
- 心血管生理学心血管生理学
- 自主神经系统的调节规则
- 疾病中的分子信号传递
背景情况:
- 自主失衡,源于失调的交感和副交感信号,是心血管疾病进展的关键因素.
- 了解自主功能障碍的分子基础对于开发有效的治疗方法至关重要.
研究的目的:
- 审查心血管疾病中自主功能障碍的分子机制.
- 突出成像和分子绘图方面的进步,揭示新的信号通路.
- 讨论恢复自主平衡的新兴治疗策略.
主要方法:
- 文献综述侧重于自主功能障碍的分子机制.
- 分析近期高分辨率成像和分子映射方面的进展.
- 综合当前和未来的治疗方法.
主要成果:
- 失调的循环AMP (cAMP) 信号传递,β-上腺素受体 (βAR) 脱敏,管音调受损,自主神经重塑有助于心血管恶化.
- 已经确定了控制第二信使分区和神经调节反循环的新途径.
- 针对特定分子通路和神经刺激的下一代治疗方法显示出有前途.
结论:
- 恢复自主平衡对于控制心血管疾病至关重要.
- 整合药理学,神经调节和分子方法提供了一个有前途的治疗前沿.
- 精确的测绘和患者特异性分析将提高自主功能障碍的治疗疗效.
相关概念视频
Imbalances in Cardiac Output
2.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.3K
Heart Failure II: Pathophysiology
722
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
722
Blood Pressure Imbalances and Circulatory Shock
1.5K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.5K
Cardiovascular Drugs: Classification based on Therapeutic Indications
4.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
932
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
932
Pathophysiology of Heart Failure
2.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.9K


